Q3 2016 13F Holders as of 9/30/2016
-
Type / Class
-
Equity / COMMON STOCK
-
Number of holders
-
172
-
Total shares
-
41.3M
-
Shares change
-
-1.74M
-
Total reported value, excl. options
-
$1.01B
-
Value change
-
-$40.6M
-
Put/Call ratio
-
6.4
-
Number of buys
-
81
-
Number of sells
-
-79
-
Price
-
$24.51
Significant Holders of AMAG PHARMACEUTICALS INC - COMMON STOCK (AMAG) as of Q3 2016
186 filings reported holding AMAG - AMAG PHARMACEUTICALS INC - COMMON STOCK as of Q3 2016.
AMAG PHARMACEUTICALS INC - COMMON STOCK (AMAG) has 172 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 41.3M shares
.
Largest 10 shareholders include JANUS CAPITAL MANAGEMENT LLC (3.5M shares), FMR LLC (3.42M shares), Palo Alto Investors, LLC (3.33M shares), BlackRock Fund Advisors (3.16M shares), VANGUARD GROUP INC (2.84M shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (2.22M shares), STATE STREET CORP (1.82M shares), D. E. Shaw & Co., Inc. (1.24M shares), STELLIAM INVESTMENT MANAGEMENT, LP (1.13M shares), and GLENMEDE TRUST CO NA (1.05M shares).
This table shows the top 172 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.